New device aims to seal brain blood vessel leaks in kids

NCT ID NCT03731000

Recruiting now Disease control Sponsor: Alejandro Berenstein Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well the PHIL Embolic System works to treat a rare brain condition in children called dural arteriovenous fistulas (DAVFs), where blood vessels connect abnormally. About 15 children under 22 will receive the treatment, which uses a special material to block the faulty vessels. The goal is to see if it is safe and effective at stopping the abnormal blood flow.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIO-VENOUS FISTULA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arteriovenous malformations of the brain congenital arteriovenous fistula dural sinus malformation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTERIO-VENOUS FISTULA INTRACRANIAL ARTERIOVENOUS MALFORMATIONS

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Mount Sinai Hospital
RECRUITING

New York, New York, 10029, United States

Contact